A collaborative initiative with American Nutraceutical Corp. advancing structured models of neural adaptation and ...
COYA 303 is an investigational proprietary combination of LD-IL-2 and GLP-1RA for subcutaneous administration, under development for the treatment of diseases, including Alzheimer's Disease, driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results